Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives
Julie E. Bauman, Umamaheswar Duvvuri, Sufi Thomas, William E. Gooding, David A. Clump, Brian Karlovits, Ahmad Wehbe, Frank R. Miller, Seungwon Kim, Malabika Sen, Dwight E. Heron, Jennifer R. Grandis, Athanassios Argiris
Profundice en los temas de investigación de 'Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives'. En conjunto forman una huella única.